NO176317C - Fremgangsmåte for fremstilling av terapeutisk aktive oksoftalazinyl-eddiksyre-derivater med benzotiazol-sidekjede - Google Patents

Fremgangsmåte for fremstilling av terapeutisk aktive oksoftalazinyl-eddiksyre-derivater med benzotiazol-sidekjede

Info

Publication number
NO176317C
NO176317C NO882516A NO882516A NO176317C NO 176317 C NO176317 C NO 176317C NO 882516 A NO882516 A NO 882516A NO 882516 A NO882516 A NO 882516A NO 176317 C NO176317 C NO 176317C
Authority
NO
Norway
Prior art keywords
acetic acid
side chain
acid derivatives
therapeutically active
benzothiazole
Prior art date
Application number
NO882516A
Other languages
English (en)
Norwegian (no)
Other versions
NO882516D0 (no
NO882516L (no
NO176317B (no
Inventor
Banavara Lakshmana Mylari
William James Zembrowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO882516D0 publication Critical patent/NO882516D0/no
Publication of NO882516L publication Critical patent/NO882516L/no
Publication of NO176317B publication Critical patent/NO176317B/no
Publication of NO176317C publication Critical patent/NO176317C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/89—Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO882516A 1987-06-09 1988-06-08 Fremgangsmåte for fremstilling av terapeutisk aktive oksoftalazinyl-eddiksyre-derivater med benzotiazol-sidekjede NO176317C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5989987A 1987-06-09 1987-06-09

Publications (4)

Publication Number Publication Date
NO882516D0 NO882516D0 (no) 1988-06-08
NO882516L NO882516L (no) 1988-12-12
NO176317B NO176317B (no) 1994-12-05
NO176317C true NO176317C (no) 1995-03-15

Family

ID=22026001

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882516A NO176317C (no) 1987-06-09 1988-06-08 Fremgangsmåte for fremstilling av terapeutisk aktive oksoftalazinyl-eddiksyre-derivater med benzotiazol-sidekjede

Country Status (26)

Country Link
EP (1) EP0295051B1 (da)
JP (1) JPH0676391B2 (da)
KR (1) KR900004698B1 (da)
CN (1) CN1024347C (da)
AT (1) ATE90347T1 (da)
AU (1) AU593742B2 (da)
CA (1) CA1321791C (da)
CS (1) CS274628B2 (da)
DD (3) DD280323A5 (da)
DE (1) DE3881583T2 (da)
DK (1) DK309988A (da)
EG (1) EG18613A (da)
ES (1) ES2040853T3 (da)
FI (1) FI93835C (da)
HU (1) HU205108B (da)
IE (1) IE61499B1 (da)
IL (1) IL86660A0 (da)
MY (1) MY103573A (da)
NO (1) NO176317C (da)
NZ (1) NZ224937A (da)
PH (1) PH25928A (da)
PL (1) PL157690B1 (da)
PT (1) PT87669B (da)
SU (1) SU1678208A3 (da)
YU (1) YU46696B (da)
ZA (1) ZA884075B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322153A3 (en) * 1987-12-21 1990-08-16 Pfizer Inc. Heterocyclic oxophtalazinyl acetic acids
WO1989006651A1 (en) * 1988-01-19 1989-07-27 Pfizer Inc. 1h-indazole-3-acetic acids as aldose reductase inhibitors
US4904782A (en) * 1988-02-29 1990-02-27 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
FR2647676A1 (fr) * 1989-06-05 1990-12-07 Union Pharma Scient Appl Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
US5304557A (en) * 1989-12-15 1994-04-19 Pfizer Inc. Substituted oxoophthalazinyl acetic acids and analogs thereof
US5064830A (en) * 1990-08-02 1991-11-12 Pfizer Inc. Lowering of blood uric acid levels
WO1992003432A1 (en) * 1990-08-28 1992-03-05 Pfizer Inc. 3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-3h-phythalazin-1-ylacetic acid monohydrate
CZ387092A3 (en) * 1991-03-28 1994-02-16 Pfizer Pyridazinoacetic acids, their derivatives, process of their preparation and use
FR2682108B1 (fr) * 1991-10-07 1994-01-07 Lipha Acide 3,4-dihydro-4-oxo-3(prop-2-enyl)-1-phtalazineacetiques et derives, leurs preparations et medicaments les contenant.
EP0652213B1 (en) * 1993-10-06 1997-08-27 SUMIKA FINE CHEMICALS Co., Ltd. Method for producing alkyl 3-phthalidylideneacetate
US5700819A (en) * 1994-11-29 1997-12-23 Grelan Pharmaceutical Co., Ltd. 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications
IL124236A (en) * 1997-05-05 2003-01-12 Pfizer Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
EP0982306A3 (en) * 1998-08-21 2000-07-05 Pfizer Products Inc. Polymorph of zopolrestat monohydrate
SG82702A1 (en) * 1999-09-28 2001-08-21 Ebauchesfabrik Eta Ag Timepiece including a movement mounted in a casing ring
CN116970317B (zh) * 2023-03-20 2024-06-25 安徽庆丰涂料科技有限公司 可呼吸的负离子抗菌涂料及其加工工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
JPS5931509B2 (ja) * 1979-06-06 1984-08-02 昭和電工株式会社 ３−ヒドロキシ−３−メチルフタリド又はその核置換体の製造法
EP0222576B1 (en) * 1985-11-07 1992-03-18 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids

Also Published As

Publication number Publication date
DD281600A5 (de) 1990-08-15
EG18613A (en) 1993-08-30
DE3881583D1 (de) 1993-07-15
EP0295051A2 (en) 1988-12-14
DD280323A5 (de) 1990-07-04
NO882516D0 (no) 1988-06-08
HU205108B (en) 1992-03-30
AU1749188A (en) 1988-12-15
CA1321791C (en) 1993-08-31
NO882516L (no) 1988-12-12
KR890000476A (ko) 1989-03-14
ES2040853T3 (es) 1993-11-01
IL86660A0 (en) 1988-11-30
CS392488A2 (en) 1990-08-14
KR900004698B1 (ko) 1990-07-02
CN88103507A (zh) 1988-12-28
YU46696B (sh) 1994-04-05
JPH0676391B2 (ja) 1994-09-28
FI93835B (fi) 1995-02-28
PT87669A (pt) 1988-07-01
FI882722A0 (fi) 1988-06-08
SU1678208A3 (ru) 1991-09-15
FI93835C (fi) 1995-06-12
EP0295051B1 (en) 1993-06-09
PH25928A (en) 1991-12-19
JPS643173A (en) 1989-01-06
ZA884075B (en) 1990-02-28
PT87669B (pt) 1992-09-30
DE3881583T2 (de) 1993-09-16
PL272899A1 (en) 1989-07-10
ATE90347T1 (de) 1993-06-15
FI882722A (fi) 1988-12-10
CN1024347C (zh) 1994-04-27
MY103573A (en) 1993-08-28
DK309988D0 (da) 1988-06-08
IE61499B1 (en) 1994-11-02
NO176317B (no) 1994-12-05
YU111188A (en) 1989-12-31
PL157690B1 (en) 1992-06-30
CS274628B2 (en) 1991-09-15
DD280320A5 (de) 1990-07-04
EP0295051A3 (en) 1989-03-22
AU593742B2 (en) 1990-02-15
NZ224937A (en) 1991-01-29
DK309988A (da) 1988-12-10
IE881716L (en) 1988-12-09

Similar Documents

Publication Publication Date Title
NO176317C (no) Fremgangsmåte for fremstilling av terapeutisk aktive oksoftalazinyl-eddiksyre-derivater med benzotiazol-sidekjede
NO175371C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminosyrederivater
NO174043C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive mettede fettsyreamider
NO176605C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive 7-(1-azetidinyl)-1,4-dihydro-4-okso-3-kinolinkarboksylsyrederivater
ATE74346T1 (de) Alkensaeurederivate.
FI890723A0 (fi) Menetelmä kinoliinikarboksyylihappojohdannaisten valmistamiseksi
IL87429A0 (en) A process for the enzymatic preparation of optically active phosphorus-containing functional acetic acid derivatives
FI903626A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 1H-indatsoli-3-etikkahappojohdannaisen valmistamiseksi
AU605754B2 (en) Process for acylating amines with 2-benzothiazolyl thioesters of carboxylic acids
EG18597A (en) Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
NO174346C (no) Fremgangsmåte for fremstilling av 5-aroyl-1,2-dihydro-3H-pyrrolo-(1,2-a)-pyrrol-1-carboxylsyrer og alkylestere og salter derav

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2001